Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-50708

Single-particle
3.1 Å
EMD-50708
3D View Gallery
Deposition: 18/06/2024
Map released: 19/03/2025
Last modified: 02/07/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-50708
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 9fr4 summary report (pdf.gz) Map and 9fr4 FULL report (pdf.gz)
EMICSS annotations (xml)

Structure of the SARS-CoV-2 spike glycoprotein in complex with nanobody 7F (local refinement)

EMD-50708

Single-particle
3.1 Å
EMD-50708
3D View Gallery
Deposition: 18/06/2024
Map released: 19/03/2025
Last modified: 02/07/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus, Lama glama
Sample: SARS2 spike glycoprotein ectodomain in complex with the 7F nanobody
Fitted models: 9fr4

Deposition Authors: Debski-Antoniak O , Drulyte I , Hurdiss DL
A bivalent spike-targeting nanobody with anti-sarbecovirus activity.
Swart IC, Debski-Antoniak OJ, Zegar A, de Bouter T, Chatziandreou M, van den Berg M, Drulyte I , Pyrc K, de Haan CAM , Hurdiss DL , Bosch BJ, Oliveira S
(2025) J Nanobiotechnology , 23 , 196 - 196
PUBMED: 40059135
DOI: doi:10.1186/s12951-025-03243-y
ISSN: 1477-3155
Grant Support: